| Literature DB >> 18778467 |
Sophie Coleman1, Kathryn Briffa, Heather Conroy, Richard Prince, Graeme Carroll, Jean McQuade.
Abstract
BACKGROUND: Self-management (SM) programs are effective for some chronic conditions, however the evidence for arthritis SM is inconclusive. The aim of this case series project was to determine whether a newly developed specific self-management program for people with osteoarthritis of the knee (OAK), implemented by health professionals could achieve and maintain clinically meaningful improvements. PARTICIPANTS: 79 participants enrolled; mean age 66, with established osteoarthritis of the knee. People with coexisting inflammatory joint disease or serious co-morbidities were excluded. INTERVENTION: 6-week disease (OA) and site (knee) specific self-management education program that included disease education, exercise advice, information on healthy lifestyle and relevant information within the constructs of self-management. This program was conducted in a community health care setting and was delivered by health professionals thereby utilising their knowledge and expertise. MEASUREMENTS: Pain, physical function and mental health scales were assessed at baseline, 8 weeks, 6 and 12 months using WOMAC and SF-36 questionnaires. Changes in pain during the 8-week intervention phase were monitored with VAS.Entities:
Mesh:
Year: 2008 PMID: 18778467 PMCID: PMC2538526 DOI: 10.1186/1471-2474-9-117
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1Flow chart time-points with number of participants attending. Baseline to week 8 (intervention), 6 months and 12 months (follow-up assessments)
Characteristics of participants enrolled in OAK program
| Index measured in quintile ranges | |
| Top 25% | 59 (74.6) |
| 50–75% | 7 (8.8) |
| 25–50% | 7 (8.8) |
| 10–25% | 3 (3.8) |
| Bottom 10% | 3 (3.8) |
| Cardiovascular, n (%) | 48 (45) |
| Mental Health, n (%) | 9 (11) |
| Gastrointestinal, n (%) | 27 (30) |
| Endocrine, n (%) | 15 (18) |
| Musculoskeletal, n (%) | 16 (20) |
| Osteoporosis, n (%) | 14 (18) |
| Multiple co-morbidities, n (%) | 51 (64.5) |
| Other, n (%) | 31 (61) |
| No co-morbidities, n (%) | 12 (15) |
*Percentage adds > 100 as some participants have more than one coexisting disease
WOMAC scores at baseline, 8 weeks, 6 months and 12 months
| BL | 8 wks | 6 mths | 12 mths | F (df) | Change at 12 mths | Effect size (d) | ||
| Pain (0 to 20) | 7.91 (0.46) | 6.57 (0.36) | 6.30 (0.39) | 5.95 (0.46) | 11.01(3,201) | < 0.001 | 1.95 (1.1 to 2.7) | 0.5 |
| Stiffness (0 to 8) | 3.88 (0.21) | 3.16 (0.19) | 3.19 (0.17) | 3.13 (0.19) | 6.19(3,201) | < 0.001 | 0.75 (0.3 to 1.1) | 0.4 |
| Function (0 to 68) | 24.98 (1.41) | 20.66 (1.28) | 19.86 (1.37) | 19.63 (1.44) | 10.02(3,201) | < 0.001 | 5.35 (2.8 to 7.8) | 0.4 |
| Total (0 to 96) | 36.77 (1.94) | 30.29 (1.66) | 29.39 (1.84) | 28.72 (2.00) | 12.25(3,201) | < 0.001 | 8.06 (4.6 to 11.4) | 0.5 |
Values are mean (SE). Lower scores indicate improvement; F-values and p-values are for repeated measures ANOVA. Change at 12 months values are mean (95% CI). Effect size is for pair wise comparison between baseline and 12 month scores.
SF-36 scores at baseline, 8 weeks, 6 months and 12 months
| Physical Function | 47.36 (2.49) | 52.00 (2.62) | 56.13 (2.62) | 55.66 (3.13) | 5.47(3,201) | < 0.001 | 7.73 (2.70 to 12.70) | 0.3 |
| Role Physical | 29.77 (4.54) | 41.54 (4.87) | 43.01 (4.99) | 46.69 (5.23) | 4.48(3,201) | 0.004 | 16.91 (7.20 to 26.50) | 0.4 |
| Bodily Pain | 35.50 (1.85) | 40.39 (2.06) | 41.52 (2.52) | 43.64 (2.49) | 3.49(3,201) | 0.017 | 8.14 (3.03 to 13.20) | 0.5 |
| General Health | 63.72 (2.58) | 67.05 (2.25) | 69.13 (2.57) | 69.79 (2.50) | 3.42(3,201) | 0.018 | 6.07 (1.50 to 10.50) | 0.3 |
| Vitality | 50.41 (2.73) | 56.38 (2.10) | 57.30 (2.41) | 60.73 (2.58) | 7.64(3,201) | < 0.001 | 10.30 (5.20 to 15.30) | 0.4 |
| Social Function | 69.64 (3.04) | 78.67 (2.46) | 76.72 (2.81) | 79.98 (2.72) | 5.16(3,201) | 0.002 | 10.30 (4.80 to 15.70) | 0.4 |
| Role Emotional | 53.97 (5.31) | 66.14 (4.81) | 71.05 (4.98) | 73.01 (4.80) | 5.27(3,201) | 0.002 | 19.04 (9.10 to 28.90) | 0.4 |
| Mental Health | 71.02 (2.25) | 77.11 (1.70) | 79.00 (1.90) | 78.73 (2.11) | 9.34(3,201) | < 0.001 | 7.70 (3.60 to 11.70) | 0.4 |
Values are mean (SE). Higher scores indicate improvement; F-values and p-values are for repeated measures ANOVA. Change at 12 months values are mean (95% CI). Effect size is for pair wise comparison between baseline and 12 month scores.